Valproic acid Completed Phase 1 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00996060Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies